May J. Reed

May J. Reed

Auto-generated profile, based on publicly available information

May J. Reed

Department of Medicine, Division of Gerontology and Geriatric Medicine, University of Washington, Seattle, WA, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2021 in Nature Aging
Verified
Journal Article
Closed access
PDF file
William BanksWilliam Banks
William Banks
MRMay J. Reed
May J. Reed
ALAric F. Logsdon
Aric F. Logsdon
ERElizabeth M. Rhea
Elizabeth M. Rhea
MEMichelle A. Erickson
Michelle A. Erickson

11 September 2019 in Tissue Barriers
Verified
Journal Article
Closed access
MRMay J. Reed
May J. Reed
MDMamatha Damodarasamy
Mamatha Damodarasamy
WBWilliam A. Banks
William A. Banks
There is increasing interest in defining the location, content, and role of extracellular matrix (ECM) components in brain structure and function during development, aging, injury, and neurodegeneration. Studies in vivo confirm brain ECM has a dynamic composition with constitutive and induced alterations that impact subsequent cell-cell and cell-matrix interactions. Moreover, it is clear that for any given ECM component, the brain region, and cell type within that location, determines the direction, magnitude, and composition of those changes. This review will examine the ECM at the neurovascular unit (NVU) and the blood–brain barrier (BBB) within the NVU. The discussion will begin at the glycocalyx ECM on the luminal surface of the vasculature, and progress to the abluminal side with a focus on changes in basement membrane ECM during aging and neurodegeneration.

18 July 2014 in Wound Repair and Regeneration
Verified
Journal Article
Closed access
PDF file
MDMamatha Damodarasamy
Mamatha Damodarasamy
RJRichard S. Johnson
Richard S. Johnson
IBItay Bentov
Itay Bentov
MMMichael J. MacCoss
Michael J. MacCoss
RVRobert B. Vernon
Robert B. Vernon
MRMay J. Reed
May J. Reed

8 January 2019 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
MRMay J. Reed
May J. Reed
MDMamatha Damodarasamy
Mamatha Damodarasamy
JPJasmine L. Pathan
Jasmine L. Pathan
CCChristina K. Chan
Christina K. Chan
CSCharles Spiekerman
Charles Spiekerman
CKC. Dirk Keene
C. Dirk Keene
Little is known about the extracellular matrix (ECM) during progression of AD pathology. Brain ECM is abundant in hyaluronan (HA), a non-sulfated glycosaminoglycan synthesized by HA synthases (HAS) 1–3 in a high molecular weight (MW) form that is deg

21 May 2018 in Journal of Histochemistry & Cytochemistry
Verified
Journal Article
Closed access
MRMay J. Reed
May J. Reed
MDMamatha Damodarasamy
Mamatha Damodarasamy
JPJasmine L. Pathan
Jasmine L. Pathan
MEMichelle A. Erickson
Michelle A. Erickson
WBWilliam A. Banks
William A. Banks
RVRobert B. Vernon
Robert B. Vernon
The brain changes in volume and composition with normal aging. Cellular components of the brain are supported by an extracellular matrix (ECM) comprised largely of hyaluronan (HA) and HA-associated members of the lectican family of chondroitin sulfate proteoglycans (CSPGs). We examined regional differences in microvascular density, neuronal and glial markers, and accumulation of HA and CSPGs in mouse brains during normal aging. The cortex, hippocampus, dentate gyrus, and cerebellum of young (4 months), middle-aged (14 months), and aged (24–26 months) brains were analyzed. Microvascular density decreased in cerebral cortex and cerebellum with age. There were no detectable differences in neuronal density. There was an increase in astrocytes in the hippocampus with aging. HA accumulation was higher in aged brain relative to young brain in the cerebral cortex and cerebellum, but not in other regions examined. In contrast, CSPGs did not change with aging in any of the brain regions examined. HA and CSPGs colocalized with a subset of neuronal cell bodies and astrocytes, and at the microvasculature. Differences in accumulation of ECM in the aging brain, in the setting of decreased microvascular density and/or increased glial activation, might contribute to age-related regional differences in vulnerability to injury and ischemia.

29 September 2020 in Fluids and Barriers of the CNS
Verified
Journal Article
Open access
PDF file
MDMamatha Damodarasamy
Mamatha Damodarasamy
RVRobert B. Vernon
Robert B. Vernon
JPJasmine L. Pathan
Jasmine L. Pathan
CKC. Dirk Keene
C. Dirk Keene
ADAnthony Day
Anthony Day
MRMay J. Reed
May J. Reed
Background: The microvasculature (MV) of brains with Alzheimer’s disease neuropathologic change (ADNC) and cerebral amyloid angiopathy (CAA), in the absence of concurrent pathologies (e.g., infarctions, Lewy bodies), is incompletely understood. Objective: To analyze microvascular density, diameter and extracellular matrix (ECM) content in association with ADNC and CAA. Methods: We examined samples of cerebral cortex and isolated brain microvasculature (MV) from subjects with the National Institute on Aging-Alzheimer's Association (NIA-AA) designations of not-, intermediate-, or high ADNC and from subjects with no CAA and moderate-severe CAA. Cases for all groups were selected with no major (territorial) strokes, ≤ 1 microinfarct in screening sections, and no Lewy body pathology. MV density and diameter were measured from cortical brain sections. Levels of basement membrane (BM) ECM components, the protein product of TNF-stimulated gene-6 (TSG-6), and the ubiquitous glycosaminoglycan hyaluronan (HA) were assayed by western blots or HA ELISA of MV lysates. Results: We found no significant changes in MV density or diameter among any of the groups. Levels of BM laminin and collagen IV (col IV) were lower in MV isolated from the high ADNC vs. not-ADNC groups. In contrast, BM laminin was significantly higher in MV from the moderate-severe CAA vs. the no CAA groups. TSG-6 and HA content were higher in the presence of both high ADNC and CAA, whereas levels of BM fibronectin and perlecan were similar among all groups. Conclusions: Cortical MV density and diameter are not appreciably altered by ADNC or CAA. TSG-6 and HA are increased in both ADNC and CAA, with laminin and col IV decreased in the BM of high ADNC, but laminin increased in moderate-severe CAA. These results show that changes in the ECM occur in AD and CAA, but independently of one another, and likely reflect on the regional functioning of the brain microvasculature.